Skip to main content
. Author manuscript; available in PMC: 2018 Jan 29.
Published in final edited form as: Virology. 2014 Jul 30;464-465:156–165. doi: 10.1016/j.virol.2014.07.004

Fig. 3.

Fig. 3

The protective efficacy of the vaccination with DK/96 virus upon challenge. Groups of 5 mice vaccinated with 5, 0.5 or 0.25 μg of DK/96-wt or DK/96-Hu virus vaccines are challenged with 106 EID50 of DK/96-wt virus at 30 days post-primary vaccination. Lungs were collected at day 4 post-challenge and titrated in eggs, expressed as mean log10 EID50 per ml+SD. There is no significance in viral titers between DK/96-wt and DK/96-Hu vaccine groups based on two-way ANOVA (p40.05).